Reduced­dose apixaban and dabigatran in patients with advanced liver cirrhosis and venous thromboembolism: a case series.

Weronska, Anna; Papuga-Szela, Elzbieta; Broniatowska, Elzbieta; Undas, Anetta

Reduceddose apixaban and dabigatran in patients with advanced liver cirrhosis and venous thromboembolism: a case series.

Weronska, Anna; Papuga-Szela, Elzbieta; Broniatowska, Elzbieta; Undas, Anetta.

Weronska A; Faculty of Medicine and Health Science, Andrzej Frycz Modrzewski Krakow University, Kraków, Poland
Papuga-Szela E; John Paul II Hospital, Kraków, Poland
Broniatowska E; Faculty of Medicine and Health Science, Andrzej Frycz Modrzewski Krakow University, Kraków, Poland
Undas A; John Paul II Hospital, Kraków, Poland; Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland. mmundas@cyf-kr.edu.pl

Pol Arch Intern Med ; 131(7-8): 762-765, 2021 08 30.

Article in English | MEDLINE | ID: covidwho-1404189

Subject(s)

Dabigatran; Venous Thromboembolism; Anticoagulants/therapeutic use; Dabigatran/adverse effects; Humans; Liver Cirrhosis/complications; Liver Cirrhosis/drug therapy; Pyrazoles; Pyridones/adverse effects; Venous Thromboembolism/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Venous Thromboembolism / Dabigatran Topics: Long Covid Limits: Humans Language: English Journal: Pol Arch Intern Med Year: 2021 Document Type: Article Affiliation country: Pamw.16024

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google